ISPOR - CE3 THE COSTS OF ADJUVANT CHEMOTHERAPY IN EARLY STAGE BREAST CANCER PATIENTS- COMPARISON OF ATTRIBUTABLE COST AND MICROCOSTING APPROACHES

Full Text

CE3 THE COSTS OF ADJUVANT CHEMOTHERAPY IN EARLY STAGE BREAST CANCER PATIENTS- COMPARISON OF ATTRIBUTABLE COST AND MICROCOSTING APPROACHES

Abstract

Authors

N Oestreicher DL Veenstra H Linden J McCune SD Ramsey

Back to Volume 7, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now